HEADER TRANSFERASE/INHIBITOR 11-JUL-18 6E2O TITLE ASK1 KINASE DOMAIN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: APOPTOSIS SIGNAL-REGULATING KINASE 1,ASK-1,MAPK/ERK KINASE COMPND 5 KINASE 5,MEKK 5; COMPND 6 EC: 2.7.11.25; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP3K5, ASK1, MAPKKK5, MEKK5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, INHIBITOR COMPLEX, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.B.LANSDON REVDAT 2 17-OCT-18 6E2O 1 JRNL REVDAT 1 19-SEP-18 6E2O 0 JRNL AUTH J.T.LILES,B.K.CORKEY,G.T.NOTTE,G.R.BUDAS,E.B.LANSDON, JRNL AUTH 2 F.HINOJOSA-KIRSCHENBAUM,S.S.BADAL,M.LEE,B.E.SCHULTZ,S.WISE, JRNL AUTH 3 S.PENDEM,M.GRAUPE,L.CASTONGUAY,K.A.KOCH,M.H.WONG, JRNL AUTH 4 G.A.PAPALIA,D.M.FRENCH,T.SULLIVAN,E.G.HUNTZICKER,F.Y.MA, JRNL AUTH 5 D.J.NIKOLIC-PATERSON,T.ALTUHAIFI,H.YANG,A.B.FOGO, JRNL AUTH 6 D.G.BRECKENRIDGE JRNL TITL ASK1 CONTRIBUTES TO FIBROSIS AND DYSFUNCTION IN MODELS OF JRNL TITL 2 KIDNEY DISEASE. JRNL REF J. CLIN. INVEST. V. 128 4485 2018 JRNL REFN ISSN 1558-8238 JRNL PMID 30024858 JRNL DOI 10.1172/JCI99768 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 26343 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.580 REMARK 3 FREE R VALUE TEST SET COUNT : 1996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.8646 - 5.7536 0.96 1881 154 0.2002 0.2182 REMARK 3 2 5.7536 - 4.5681 0.98 1811 148 0.1979 0.2577 REMARK 3 3 4.5681 - 3.9910 0.98 1777 147 0.1769 0.2332 REMARK 3 4 3.9910 - 3.6262 0.99 1785 146 0.2033 0.2343 REMARK 3 5 3.6262 - 3.3664 0.99 1781 146 0.2199 0.2879 REMARK 3 6 3.3664 - 3.1680 0.98 1761 145 0.2313 0.3002 REMARK 3 7 3.1680 - 3.0094 0.98 1730 142 0.2426 0.3215 REMARK 3 8 3.0094 - 2.8784 0.97 1743 143 0.2344 0.3072 REMARK 3 9 2.8784 - 2.7676 0.97 1724 141 0.2314 0.3112 REMARK 3 10 2.7676 - 2.6721 0.97 1729 141 0.2319 0.3300 REMARK 3 11 2.6721 - 2.5885 0.96 1702 140 0.2303 0.2995 REMARK 3 12 2.5885 - 2.5146 0.96 1688 138 0.2447 0.3057 REMARK 3 13 2.5146 - 2.4484 0.94 1648 135 0.2694 0.3661 REMARK 3 14 2.4484 - 2.3886 0.89 1587 130 0.2887 0.3809 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 4236 REMARK 3 ANGLE : 1.124 5717 REMARK 3 CHIRALITY : 0.061 609 REMARK 3 PLANARITY : 0.007 730 REMARK 3 DIHEDRAL : 21.781 2551 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6E2O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1000235606. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61441 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.50900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG 400, 3% PPE 400, 100MM BIS REMARK 280 -TRIS PH 7.5, 10MM TCEP, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.31850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.24100 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.31850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 78.24100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1131 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 657 REMARK 465 SER A 658 REMARK 465 ARG A 659 REMARK 465 SER A 660 REMARK 465 THR A 661 REMARK 465 GLU A 662 REMARK 465 GLU A 663 REMARK 465 GLY A 664 REMARK 465 ASP A 665 REMARK 465 CYS A 666 REMARK 465 GLU A 667 REMARK 465 SER A 668 REMARK 465 ASP A 669 REMARK 465 ARG A 714 REMARK 465 ASP A 715 REMARK 465 GLY A 831 REMARK 465 ILE A 832 REMARK 465 ASN A 833 REMARK 465 PRO A 834 REMARK 465 VAL A 940 REMARK 465 SER A 941 REMARK 465 SER A 942 REMARK 465 LYS A 943 REMARK 465 LYS A 944 REMARK 465 LYS A 945 REMARK 465 LYS A 946 REMARK 465 THR A 947 REMARK 465 GLN A 948 REMARK 465 PRO A 949 REMARK 465 LYS A 950 REMARK 465 LEU A 951 REMARK 465 GLY B 657 REMARK 465 SER B 658 REMARK 465 ARG B 659 REMARK 465 SER B 660 REMARK 465 THR B 661 REMARK 465 GLU B 662 REMARK 465 GLU B 663 REMARK 465 GLY B 664 REMARK 465 ASP B 665 REMARK 465 CYS B 666 REMARK 465 GLU B 667 REMARK 465 SER B 668 REMARK 465 ASP B 669 REMARK 465 LEU B 670 REMARK 465 ARG B 714 REMARK 465 ASP B 715 REMARK 465 SER B 716 REMARK 465 ARG B 717 REMARK 465 TYR B 718 REMARK 465 ALA B 830 REMARK 465 GLY B 831 REMARK 465 ILE B 832 REMARK 465 ASN B 833 REMARK 465 PRO B 834 REMARK 465 CYS B 835 REMARK 465 THR B 836 REMARK 465 GLU B 837 REMARK 465 TPO B 838 REMARK 465 PHE B 839 REMARK 465 GLY B 854 REMARK 465 PRO B 855 REMARK 465 ARG B 856 REMARK 465 GLY B 857 REMARK 465 VAL B 940 REMARK 465 SER B 941 REMARK 465 SER B 942 REMARK 465 LYS B 943 REMARK 465 LYS B 944 REMARK 465 LYS B 945 REMARK 465 LYS B 946 REMARK 465 THR B 947 REMARK 465 GLN B 948 REMARK 465 PRO B 949 REMARK 465 LYS B 950 REMARK 465 LEU B 951 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 856 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 802 -9.05 81.18 REMARK 500 ASP A 822 88.15 63.47 REMARK 500 GLU A 837 -33.98 -133.01 REMARK 500 LEU A 884 -7.01 -53.79 REMARK 500 GLU A 886 151.01 -47.12 REMARK 500 LYS A 898 33.14 76.54 REMARK 500 ASP B 678 -174.05 -68.32 REMARK 500 LYS B 733 114.63 -160.99 REMARK 500 GLN B 798 51.36 37.43 REMARK 500 ASP B 803 42.40 -145.64 REMARK 500 ASP B 822 98.76 53.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue S0L A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue S0L B 1001 DBREF 6E2O A 659 951 UNP Q99683 M3K5_HUMAN 659 951 DBREF 6E2O B 659 951 UNP Q99683 M3K5_HUMAN 659 951 SEQADV 6E2O GLY A 657 UNP Q99683 EXPRESSION TAG SEQADV 6E2O SER A 658 UNP Q99683 EXPRESSION TAG SEQADV 6E2O GLY B 657 UNP Q99683 EXPRESSION TAG SEQADV 6E2O SER B 658 UNP Q99683 EXPRESSION TAG SEQRES 1 A 295 GLY SER ARG SER THR GLU GLU GLY ASP CYS GLU SER ASP SEQRES 2 A 295 LEU LEU GLU TYR ASP TYR GLU TYR ASP GLU ASN GLY ASP SEQRES 3 A 295 ARG VAL VAL LEU GLY LYS GLY THR TYR GLY ILE VAL TYR SEQRES 4 A 295 ALA GLY ARG ASP LEU SER ASN GLN VAL ARG ILE ALA ILE SEQRES 5 A 295 LYS GLU ILE PRO GLU ARG ASP SER ARG TYR SER GLN PRO SEQRES 6 A 295 LEU HIS GLU GLU ILE ALA LEU HIS LYS HIS LEU LYS HIS SEQRES 7 A 295 LYS ASN ILE VAL GLN TYR LEU GLY SER PHE SER GLU ASN SEQRES 8 A 295 GLY PHE ILE LYS ILE PHE MET GLU GLN VAL PRO GLY GLY SEQRES 9 A 295 SER LEU SER ALA LEU LEU ARG SER LYS TRP GLY PRO LEU SEQRES 10 A 295 LYS ASP ASN GLU GLN THR ILE GLY PHE TYR THR LYS GLN SEQRES 11 A 295 ILE LEU GLU GLY LEU LYS TYR LEU HIS ASP ASN GLN ILE SEQRES 12 A 295 VAL HIS ARG ASP ILE LYS GLY ASP ASN VAL LEU ILE ASN SEQRES 13 A 295 THR TYR SER GLY VAL LEU LYS ILE SER ASP PHE GLY THR SEQRES 14 A 295 SER LYS ARG LEU ALA GLY ILE ASN PRO CYS THR GLU TPO SEQRES 15 A 295 PHE THR GLY THR LEU GLN TYR MET ALA PRO GLU ILE ILE SEQRES 16 A 295 ASP LYS GLY PRO ARG GLY TYR GLY LYS ALA ALA ASP ILE SEQRES 17 A 295 TRP SER LEU GLY CYS THR ILE ILE GLU MET ALA THR GLY SEQRES 18 A 295 LYS PRO PRO PHE TYR GLU LEU GLY GLU PRO GLN ALA ALA SEQRES 19 A 295 MET PHE LYS VAL GLY MET PHE LYS VAL HIS PRO GLU ILE SEQRES 20 A 295 PRO GLU SER MET SER ALA GLU ALA LYS ALA PHE ILE LEU SEQRES 21 A 295 LYS CYS PHE GLU PRO ASP PRO ASP LYS ARG ALA CYS ALA SEQRES 22 A 295 ASN ASP LEU LEU VAL ASP GLU PHE LEU LYS VAL SER SER SEQRES 23 A 295 LYS LYS LYS LYS THR GLN PRO LYS LEU SEQRES 1 B 295 GLY SER ARG SER THR GLU GLU GLY ASP CYS GLU SER ASP SEQRES 2 B 295 LEU LEU GLU TYR ASP TYR GLU TYR ASP GLU ASN GLY ASP SEQRES 3 B 295 ARG VAL VAL LEU GLY LYS GLY THR TYR GLY ILE VAL TYR SEQRES 4 B 295 ALA GLY ARG ASP LEU SER ASN GLN VAL ARG ILE ALA ILE SEQRES 5 B 295 LYS GLU ILE PRO GLU ARG ASP SER ARG TYR SER GLN PRO SEQRES 6 B 295 LEU HIS GLU GLU ILE ALA LEU HIS LYS HIS LEU LYS HIS SEQRES 7 B 295 LYS ASN ILE VAL GLN TYR LEU GLY SER PHE SER GLU ASN SEQRES 8 B 295 GLY PHE ILE LYS ILE PHE MET GLU GLN VAL PRO GLY GLY SEQRES 9 B 295 SER LEU SER ALA LEU LEU ARG SER LYS TRP GLY PRO LEU SEQRES 10 B 295 LYS ASP ASN GLU GLN THR ILE GLY PHE TYR THR LYS GLN SEQRES 11 B 295 ILE LEU GLU GLY LEU LYS TYR LEU HIS ASP ASN GLN ILE SEQRES 12 B 295 VAL HIS ARG ASP ILE LYS GLY ASP ASN VAL LEU ILE ASN SEQRES 13 B 295 THR TYR SER GLY VAL LEU LYS ILE SER ASP PHE GLY THR SEQRES 14 B 295 SER LYS ARG LEU ALA GLY ILE ASN PRO CYS THR GLU TPO SEQRES 15 B 295 PHE THR GLY THR LEU GLN TYR MET ALA PRO GLU ILE ILE SEQRES 16 B 295 ASP LYS GLY PRO ARG GLY TYR GLY LYS ALA ALA ASP ILE SEQRES 17 B 295 TRP SER LEU GLY CYS THR ILE ILE GLU MET ALA THR GLY SEQRES 18 B 295 LYS PRO PRO PHE TYR GLU LEU GLY GLU PRO GLN ALA ALA SEQRES 19 B 295 MET PHE LYS VAL GLY MET PHE LYS VAL HIS PRO GLU ILE SEQRES 20 B 295 PRO GLU SER MET SER ALA GLU ALA LYS ALA PHE ILE LEU SEQRES 21 B 295 LYS CYS PHE GLU PRO ASP PRO ASP LYS ARG ALA CYS ALA SEQRES 22 B 295 ASN ASP LEU LEU VAL ASP GLU PHE LEU LYS VAL SER SER SEQRES 23 B 295 LYS LYS LYS LYS THR GLN PRO LYS LEU MODRES 6E2O TPO A 838 THR MODIFIED RESIDUE HET TPO A 838 11 HET S0L A1001 31 HET S0L B1001 31 HETNAM TPO PHOSPHOTHREONINE HETNAM S0L 4-(4-CYCLOPROPYL-1H-IMIDAZOL-1-YL)-N-[3-(4-CYCLOPROPYL- HETNAM 2 S0L 4H-1,2,4-TRIAZOL-3-YL)PHENYL]PYRIDINE-2-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 S0L 2(C23 H21 N7 O) FORMUL 5 HOH *69(H2 O) HELIX 1 AA1 TYR A 718 LYS A 730 1 13 HELIX 2 AA2 SER A 761 LYS A 769 1 9 HELIX 3 AA3 ASN A 776 ASN A 797 1 22 HELIX 4 AA4 THR A 842 MET A 846 5 5 HELIX 5 AA5 ALA A 847 ASP A 852 1 6 HELIX 6 AA6 LYS A 860 GLY A 877 1 18 HELIX 7 AA7 GLU A 886 LYS A 898 1 13 HELIX 8 AA8 SER A 908 PHE A 919 1 12 HELIX 9 AA9 CYS A 928 VAL A 934 1 7 HELIX 10 AB1 ASP A 935 LYS A 939 5 5 HELIX 11 AB2 GLN B 720 LYS B 730 1 11 HELIX 12 AB3 LEU B 762 LYS B 769 1 8 HELIX 13 AB4 ASN B 776 ASN B 797 1 22 HELIX 14 AB5 THR B 842 MET B 846 5 5 HELIX 15 AB6 ALA B 847 ASP B 852 1 6 HELIX 16 AB7 GLY B 859 GLY B 877 1 19 HELIX 17 AB8 PHE B 881 GLY B 885 5 5 HELIX 18 AB9 GLU B 886 LYS B 898 1 13 HELIX 19 AC1 SER B 908 PHE B 919 1 12 HELIX 20 AC2 CYS B 928 VAL B 934 1 7 SHEET 1 AA1 3 TYR A 673 TYR A 675 0 SHEET 2 AA1 3 GLY A 692 ASP A 699 -1 O ARG A 698 N ASP A 674 SHEET 3 AA1 3 VAL A 685 GLY A 689 -1 N GLY A 689 O GLY A 692 SHEET 1 AA2 5 TYR A 673 TYR A 675 0 SHEET 2 AA2 5 GLY A 692 ASP A 699 -1 O ARG A 698 N ASP A 674 SHEET 3 AA2 5 ARG A 705 PRO A 712 -1 O ILE A 708 N TYR A 695 SHEET 4 AA2 5 PHE A 749 GLU A 755 -1 O MET A 754 N ALA A 707 SHEET 5 AA2 5 TYR A 740 SER A 745 -1 N GLY A 742 O PHE A 753 SHEET 1 AA3 2 TYR A 677 ASP A 678 0 SHEET 2 AA3 2 ASP A 682 ARG A 683 -1 O ASP A 682 N ASP A 678 SHEET 1 AA4 2 ILE A 799 VAL A 800 0 SHEET 2 AA4 2 LYS A 827 ARG A 828 -1 O LYS A 827 N VAL A 800 SHEET 1 AA5 2 VAL A 809 ILE A 811 0 SHEET 2 AA5 2 LEU A 818 ILE A 820 -1 O LYS A 819 N LEU A 810 SHEET 1 AA6 3 TYR B 673 TYR B 675 0 SHEET 2 AA6 3 ILE B 693 ASP B 699 -1 O ARG B 698 N ASP B 674 SHEET 3 AA6 3 VAL B 685 LYS B 688 -1 N LEU B 686 O VAL B 694 SHEET 1 AA7 5 TYR B 673 TYR B 675 0 SHEET 2 AA7 5 ILE B 693 ASP B 699 -1 O ARG B 698 N ASP B 674 SHEET 3 AA7 5 ARG B 705 PRO B 712 -1 O ILE B 708 N TYR B 695 SHEET 4 AA7 5 PHE B 749 GLU B 755 -1 O MET B 754 N ALA B 707 SHEET 5 AA7 5 TYR B 740 GLU B 746 -1 N GLY B 742 O PHE B 753 SHEET 1 AA8 3 GLY B 759 SER B 761 0 SHEET 2 AA8 3 VAL B 809 ASN B 812 -1 O ILE B 811 N GLY B 760 SHEET 3 AA8 3 LEU B 818 ILE B 820 -1 O LYS B 819 N LEU B 810 SHEET 1 AA9 2 ILE B 799 VAL B 800 0 SHEET 2 AA9 2 LYS B 827 ARG B 828 -1 O LYS B 827 N VAL B 800 LINK C GLU A 837 N TPO A 838 1555 1555 1.35 LINK C TPO A 838 N PHE A 839 1555 1555 1.31 SITE 1 AC1 18 LEU A 686 GLY A 689 ALA A 707 LYS A 709 SITE 2 AC1 18 VAL A 738 MET A 754 GLU A 755 GLN A 756 SITE 3 AC1 18 VAL A 757 GLY A 759 ASP A 807 ASN A 808 SITE 4 AC1 18 LEU A 810 SER A 821 ASP A 822 HOH A1119 SITE 5 AC1 18 TYR B 814 S0L B1001 SITE 1 AC2 20 TYR A 814 S0L A1001 LEU B 686 LYS B 688 SITE 2 AC2 20 GLY B 689 ALA B 707 LYS B 709 VAL B 738 SITE 3 AC2 20 MET B 754 GLU B 755 GLN B 756 VAL B 757 SITE 4 AC2 20 GLY B 759 ASP B 807 ASN B 808 LEU B 810 SITE 5 AC2 20 SER B 821 ASP B 822 HOH B1110 HOH B1115 CRYST1 39.632 106.637 156.482 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025232 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009378 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006391 0.00000